Barron's Insider Purchases 12-08-2007
3789 views
Rate Now: 1 2 3 4

average rating: 0.00 / 0 ratings
Created by barrons2
DESCRIPTION:

Date updated:12-09-2007

Largest insider purchases mentioned in this week's Barron's. Insider purchasing is a more reliable indicator than selling.

symbol name last price % change open
  • +
  • PBY
    Pep Boys Man Moe
  • $8.87
  • 0.00%
  • $8.77

Nine different directors and officers bought 666,500 shares or $7,420,351 worth of stock.

People owning PBY also tend to own: DENNDRTEHNZIASGJRCCMCDNOOF

TheStreet.com Rating: C- What is this?

  • +
  • CENT
    Central Garden &
  • $10.28
  • -4.81%
  • $10.53

The CEO and a director bought 1,025,000 shares or $5,159,017 worth of stock.

People owning CENT also tend to own: TOPPBWTRCREEEBSGMKTJBLJOBS

TheStreet.com Rating: C+ What is this?

  • +
  • PCX
    Patriot Coal Corp
  • $12.45
  • -0.40%
  • $12.12

A officer bought 95,700 shares or $3,292,110 worth of stock.

People owning PCX also tend to own: ACHAMZNBRKBBTUCHLCMDELL

TheStreet.com Rating: D- What is this?

  • +
  • SUSS
    Susser Holdings C
  • $12.20
  • -0.97%
  • $12.40

Two officers bought 130,000 shares or $2,926,300 worth of stock.

People owning SUSS also tend to own: DENNHBIIMKTASBHALGTHLEXSWSI

TheStreet.com Rating: C What is this?

  • +
  • SGMS
    Scientific Games
  • $14.98
  • -0.73%
  • $14.90

A director bought 70,647 shares or $2,296,028 worth of stock.

People owning SGMS also tend to own: ASCABYDHETIGTISLELVSMGAM

TheStreet.com Rating: C- What is this?

  • +
  • BKD
    Brookdale Senior
  • $17.75
  • -0.28%
  • $17.58

The CEO bought 76,400 shares or $2,189,058 worth of stock.

People owning BKD also tend to own: AYRCNEDSXEGLEGHSHTENAT

TheStreet.com Rating: D What is this?

  • +
  • FABK
    First Advantage B
  • $10.20
  • 0.00%
  • $N/A

The CEO, 2 director and 2 officers bought 202,047 shares or $2,025,206 worth of stock.

People owning FABK also tend to own: ADGO.OBBECNBKDCAPBCENTCLPCSNT

TheStreet.com Rating: D+ What is this?

  • +
  • ORNG
    Orange 21 Inc.
  • $0.7999
  • 0.00%
  • $N/A

A director bought 391,500 shares or $1,848,582 worth of stock.

People owning ORNG also tend to own: DRRXIONMTSXBDYBLGCVNSPKTR

TheStreet.com Rating: D What is this?

previous next

Portfolio not tracked!

Comments not available

ADD YOUR COMMENTS:

Jim Cramer's Portfolios of the Week

By Roberto Pedone Posted on Nov. 6, 2009 According to Jim Cramer, the bears are tellinginvestors six lies. On Wednesday’s “Mad Money” TV show, Cramer said if you ...

11.06.09 | 15:52 PM
'Fast Money' Portfolios of the Week

By Roberto Pedone Posted on Nov. 5, 2009 The traders on CNBC’s “Fast Money” told their viewers what they must know after Warren Buffett announced on Tuesday his l...

11.05.09 | 12:05 PM
Squeezing the Shorts: Late Earni...

By Jonas Elmerraji Posted on Nov. 4, 2009 For investors who seek out short-squeeze opportunities, there’s no time as important as earnings season. Earnings are one of...

11.04.09 | 15:18 PM
Cramer's Take on Headline Stocks...

By Stockpickr Staff Posted on Nov. 4, 2009 Regardless of why a stock is in the news, it never hurts to hear what a professional investor has to say about it. The key is...

11.04.09 | 11:12 AM
more articles
General market Technical Analysi...
11.14.07 | 22:55 PM From author ZA
Wealth distribution by race and ...
11.23.08 | 18:44 PM From author Valerie J
Full Disclosure
11.09.08 | 12:30 PM From author alchemist
Nymph's Trading Daily Trading Diary
04.13.09 | 01:10 AM From author Trading Nymph
more forums
Q. Pages 78 - 80 of the healthcare ...
11.08.09 | 08:45 AM Asked by Karen Schubeck

A. Type II Diabetes in obese patients is
wrecking our health care system.
Overall, more than $1 in every $10 spent
on health care in the United States goes
toward treating Diabetes. Blood glucose
test strips alone can cost about a
dollar each and if you're testing
several times a day every day, the costs
can add up pretty quickly. XOMA has the
first drug "XOMA 052" in the last 10yrs
which will significantly impact this
industry and you would no longer require
daily insulin injections or insulin at
all, for that matter. This would save
the government billions, search on that
one and you'll make a fortune. The
government cannot continue to pay these
kinds of rising diabetes costs, when
there is an alternative which is so safe
and so effective which just became
patented in Europe.

today 's lists
52-Week Highs

Here are some of the biggest stocks that made the 52-week high list on Nov. 2, 2009. more

Analyst Upgrades

Analyst Upgrades for Nov. 2, 2009. Read more here. more

Biggest % Losers

Here is the stock list of some of the largest % losers from Nov. 2, 2009. more